Kairos Pharma, Ltd. (KAPA) Insider Trading Activity

AMEX$0.5199+0.01 (1.98%)
Market Cap
$1.71M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
613 of 849
Rank in Industry
356 of 491

KAPA Insider Trading Activity

KAPA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Kairos Pharma, Ltd.

Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company focused on developing innovative treatments for individuals battling cancer. Its therapeutic portfolio includes a range of antibodies and small molecules engineered to combat various malignancies, such as prostate, lung, and breast cancer, as well as glioblastoma. Initially incorporated in 2013 under the name NanoGB13, Inc., the enterprise officially adopted its current identity as Kairos Pharma, Ltd. in July 2016. The company's operations are headquartered in Los …

Insider Activity of Kairos Pharma, Ltd.

Over the last 12 months, insiders at Kairos Pharma, Ltd. have bought $0 and sold $0 worth of Kairos Pharma, Ltd. stock.

On average, over the past 5 years, insiders at Kairos Pharma, Ltd. have bought $9,828 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 200 shares for transaction amount of $318 was made by Murali Ramachandran (VP of Research and Development) on 2024‑11‑25.

List of Insider Buy and Sell Transactions, Kairos Pharma, Ltd.

2024-11-25PurchaseMurali RamachandranVP of Research and Development
200
0.0016%
$1.59
$318
-37.35%
2024-11-22PurchaseSamuelson DougChief Financial Officer
2,500
0.0173%
$1.50
$3,750
-33.13%
2024-11-20PurchaseYu John SCEO and Chairman
4,000
0.0311%
$1.44
$5,760
-26.03%
Total: 3

KAPA Institutional Investors: Active Positions

Increased Positions8+44.44%482,860+108.5%
Decreased Positions7-38.89%72,161-16.22%
New Positions5New391,522New
Sold Out Positions5Sold Out70,261Sold Out
Total Postitions19+5.56%855,718+92.29%

KAPA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$96.000.63%131,828+131,828New2025-09-30
Geode Capital Management, Llc$48.000.31%65,800+43,996+201.78%2025-09-30
Two Sigma Investments, Lp$33.000.22%45,789+45,789New2025-09-30
Aptus Capital Advisors, Llc$32.000.21%44,28600%2025-09-30
Sevenbridge Financial Group, Llc$32.000.21%44,28600%2025-09-30
Two Sigma Securities, Llc$18.000.12%24,895+11,340+83.66%2025-09-30
State Street Corp$18.000.12%24,100+24,100New2025-09-30
Fny Investment Advisers, Llc$17.000.11%23,500+23,500New2025-09-30
Quadrature Capital Ltd$11.000.07%14,887+14,887New2025-09-30
Xtx Topco Ltd$9.000.06%12,408-50,338-80.22%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.